Mortalidade prematura por doença cardiovascular no transtorno bipolar: fatores de risco e implicações no tratamento
DOI:
https://doi.org/10.25118/2236-918X-6-5-6Palabras clave:
Transtorno bipolar, mortalidade prematura, doença cardiovascular, fatores de riscoResumen
Indivíduos com transtorno bipolar apresentam risco significativo para altas taxas de comorbidade médica com fatores de risco cardiovascular. Doenças cardiovasculares têm sido reconhecidas como a principal causa de morte nessa população. Este artigo sumariza as evidências de associação entre mortalidade cardiovascular e transtorno bipolar, assim como as recomendações para a prevenção e o manejo de hipertensão, dislipidemia, diabetes, obesidade, síndrome metabólica e tabagismo em vigência do tratamento do transtorno bipolar.
Descargas
Métricas
Citas
De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in pati ents with severe mental disorders. I. Prevalence, impact of medicati ons and dispariti es in health care. World Psychiatry. 2011;10:52-77.
Sylvia LG, Shelton RC, Kemp DE, Bernstein EE, Friedman ES, Brody BD, et al. Medical burden in bipolar disorder: fi ndings from the Clinical and Health Outcomes Initi ati ve in Comparati ve Eff ecti veness for Bipolar Disorder study (Bipolar CHOICE). Bipolar Disord. 2015;17:212-23.
Roshanaei-Moghaddam B, Katon W. Premature mortality from general medical illnesses among persons with bipolar disorder: a review. Psychiatr Serv. 2009;60:147-56.
Laursen TM. Life expectancy among persons with schizophrenia or bipolar aff ecti ve disorder. Schizophr Res. 2011;131:101-4.
Hayes JF, Miles J, Walters K, King M, Osborn DP. A systemati c review and meta-analysis of premature mortality in bipolar aff ecti ve disorder. Acta Psychiatr Scand. 2015;131:417-25.
Goldstein BI, Carnethon MR, Matt hews KA, McIntyre RS, Miller GE, Raghuveer G, et al. Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease: a scienti fi c statement from the American Heart Associati on. Circulati on. 2015;132:965-86.
Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med. 2009;71:598-606.
Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord. 2009;11:657-62.
Gomes FA, Almeida KM, Magalhães PV, Caetano SC, Kauer-Sant’Anna M, Lafer B, et al. Cardiovascular risk factors in outpatients with bipolar disorder: a report from the Brazilian research network in bipolar disorder. Rev Bras Psiquiatr. 2013;35:126-30.
de Almeida KM, de Macedo-Soares MB, Kluger Issler C, Antonio Amaral J, Caetano SC, da Silva Dias R, et al. Obesity and metabolic syndrome in Brazilian patients with bipolar disorder. Acta Neuropsychiatr. 2009;21:84-8.
Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844-50.
Daumit GL, Anthony CB, Ford DE, Fahey M, Skinner EA, Lehman AF, et al. Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res. 2010;176:242-5.
Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. BMJ. 2011;343:d5422.
Laursen TM, Wahlbeck K, Hällgren J, Westman J, Ösby U, Alinaghizadeh H, et al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. PLoS One. 2013;8:e67133.
Osborn DP, Hardoon S, Omar RZ, Holt RI, King M, Larsen J, et al. Cardiovascular risk prediction models for people with severe mental illness: results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry. 2015;72:143-51.
de Almeida KM, Moreira CL, Lafer B. Metabolic syndrome and bipolar disorder: what should psychiatrists know? CNS Neurosci Ther. 2012;18:160-6.
Ng F, Mammen OK, Wilting I, Sachs GS, Ferrier IN, Cassidy F, et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord. 2009;11:559-95.
Bauer IE, Gálvez JF, Hamilton JE, Balanzá-Martínez V, Zunta-Soares GB, Soares JC, et al. Lifestyle interventions targeting dietary habits and exercise in bipolar disorder: a systematic review. J Psychiatr Res. 2016;74:1-7.
Kilbourne AM, Cornelius JR, Han X, Pincus HA, Shad M, Salloum I, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368-73.
Chien IC, Lin CH, Chou YJ, Chou P. Risk of hypertension in patients with bipolar disorder in Taiwan: a population-based study. Compr Psychiatry. 2013;54:687-93.
Johannessen L, Strudsholm U, Foldager L, Munk-Jørgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95:13-7.
Kouidrat Y, Amad A, De Hert M. Emerging drugs and indications for cardio-metabolic disorders in people with severe mental illness. Curr Pharm Des. 2015;21:3317-24.
Gierisch JM, Nieuwsma JA, Bradford DW, Wilder CM, Mann-Wrobel MC, McBroom AJ, et al. Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysis. J Clin Psychiatry. 2014;75:e424-40.
Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15:166-74.
Calkin CV, Gardner DM, Ransom T, Alda M. The relationship between bipolar disorder and type2 diabetes: more than just co-morbid disorders. Ann Med. 2013;45:171-81.
Chamberlain JJ, Rhinehart AS, Shaefer CF Jr, Neuman A. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Associati on Standards of medical care in diabetes. Ann Intern Med. 2016;164:542-52.
Goldstein TR, Goldstein BI, Mantz MB, Bailey B, Douaihy A. A brief moti vati onal interventi on for preventi ng medicati on-associated weight gain among youth with bipolar disorder: treatment development and case report. J Child Adolesc Psychopharmacol. 2011;21:275-80.
Correll CU, Detraux J, De Lepeleire J, De Hert M. Eff ects of anti psychoti cs, anti depressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14:119-36.
Frank E, Wallace ML, Hall M, Hasler B, Levenson JC, Janney CA, et al. An integrated risk reducti on interventi on can reduce body mass index in individuals being treated for bipolar I disorder: results from a randomized trial. Bipolar Disord. 2015;17:424-37.
Alberti KG, Zimmet PZ. Defi niti on, diagnosis and classifi cati on of diabetes mellitus and its complicati ons. Part 1: diagnosis and classifi cati on of diabetes mellitus provisional report of a WHO consultati on. Diabet Med 1998;15:539-53.
Nati onal Cholesterol Educati on Program (NCEP) Expert Panel on Detecti on, Evaluati on, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the Nati onal Cholesterol Educati on Program (NCEP) expert panel on detecti on, evaluati on, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) fi nal report. Circulati on 2002;106:3143-421.
American Heart Associati on; Nati onal Heart, Lung, and Blood Insti tue, Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. Diagnosis and management of the metabolic syndrome. An American Heart Associati on/Nati onal Heart, Lung, and Blood Insti tute Scienti fi c Statement. Executi ve summary. Cardiol Rev. 2005;13:322-7.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the Internati onal Diabetes Federati on Task Force on Epidemiology and Preventi on; Nati onal Heart, Lung, and Blood Insti tute; American Heart Associati on; World Heart Federati on; Internati onal Atherosclerosis Society; and Internati onal Associati on for the Study of Obesity. Circulati on. 2009;120:1640-5.
Vancampfort D, Vansteelandt K, Correll CU, Mitchell AJ, De Herdt A, Sienaert P, et al. Metabolic syndrome and metabolic abnormaliti es in bipolar disorder: a metaanalysis of prevalence rates and moderators. Am J Psychiatry. 2013;170:265-74.
Waxmonsky JA, Thomas MR, Miklowitz DJ, Allen MH, Wisniewski SR, Zhang H, et al. Prevalence and correlates of tobacco use in bipolar disorder: data from the fi rst 2000 parti cipants in the Systemati c Treatment Enhancement Program. Gen Hosp Psychiatry. 2005;27:321-8.
Garcia-Porti lla MP, Garcia-Alvarez L, Sarramea F, Galvan G, Diaz-Mesa E, Bobes-Bascaran T, et al. It is feasible and eff ecti ve to help pati ents with severe mental disorders to quit smoking: an ecological pragmati c clinical trial with transdermal nicoti ne patches and varenicline. Schizophr Res. 2016;176:272-80.
Callaghan RC, Veldhuizen S, Jeysingh T, Orlan C, Graham C, Kakouris G, et al. Patt erns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression. J Psychiatr Res. 2014;48:102-10.
Cerimele JM, Halperin AC, Saxon AJ. Tobacco use treatment in primary care pati ents with psychiatric illness. J Am Board Fam Med. 2014;27:399-410.
Pacchiarotti I, Bond DJ, Baldessarini RJ, Nolen WA, Grunze H, Licht RW, et al. The Internati onalSociety for Bipolar Disorders (ISBD) task force report on anti depressant use in bipolar disorders. Am J Psychiatry. 2013;170:1249-62.
Leboyer M, Kupfer DJ. Bipolar disorder: new perspecti ves in health care and preventi on. J Clin Psychiatry. 2010;71:1689-95.
De Hert M, Cohen D, Bobes J, Cetkovich- Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in pati ents with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendati ons at the system and individual level. World Psychiatry. 2011;10:138-51.
Kisely S, Preston N, Xiao J, Lawrence D, Louise S, Crowe E. Reducing all-cause mortality among pati ents with psychiatric disorders: a populati onbased study. CMAJ. 2013;185:E50-6.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Debates em Psiquiatria permite que el (los) autor (es) mantenga(n) sus derechos de autor sin restricciones. Permite al (los) autor (es) conservar sus derechos de publicación sin restricciones. Los autores deben garantizar que el artículo es un trabajo original sin fabricación, fraude o plagio; no infringe ningún derecho de autor o derecho de propiedad de terceros. Los autores también deben garantizar que cada uno atendió a los requisitos de autoría conforme a la recomendación del ICMJE y entienden que, si el artículo o parte de él es fallido o fraudulento, cada autor comparte la responsabilidad.
Reconocimiento-NoComercial 4.0 internacional (CC BY-NC 4.0) - Debates em Psiquiatria es regida por la licencia CC-BY-NC
Usted es libre de:
- Compartir — copiar y redistribuir el material en cualquier medio o formato
- Adaptar — remezclar, transformar y crear a partir del material
El licenciador no puede revocar estas libertades mientras cumpla con los términos de la licencia. Bajo las condiciones siguientes:
- Reconocimiento — Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios<. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.
- NoComercial — No puede utilizar el material para una finalidad comercial.
No hay restricciones adicionales — No puede aplicar términos legales o medidas tecnológicas que legalmente restrinjan realizar aquello que la licencia permite.
